...
首页> 外文期刊>Oncology letters >Inhibiting the proliferation and metastasis of hilar cholangiocarcinoma cells by blocking the expression of vascular endothelial growth factor with small interfering RNA
【24h】

Inhibiting the proliferation and metastasis of hilar cholangiocarcinoma cells by blocking the expression of vascular endothelial growth factor with small interfering RNA

机译:通过阻断小干扰RNA来抑制血管内皮生长因子的表达来抑制蚕龟胆管癌细胞的增殖和转移

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study was to investigate whether the proliferation and metastasis of hilar cholangiocarcinoma cells can be suppressed and whether apoptosis can be induced by small interfering RNA (siRNA) repression of vascular endothelial growth factor (VEGF). siRNA sequences targeting the VEGF gene were designed and the human hilar cholangiocarcinoma QBC939, HCCC-9810 and RBE cell lines were transfected with VEGF-siRNA plasmids for 48 h. Reverse transcription-quantitative polymerase chain reaction and western blotting measured the levels of VEGF-A, VEGF-C and matrix metalloproteinase 2 (MMP2) mRNA expression and protein content. The cell invasion potential was evaluated using the Transwell invasion and migration assay and the MTT assay was employed to detect the proliferation of hilar cholangiocarcinoma cells. Flow cytometry was used to quantify cell apoptosis and necrosis. Following the transfection of VEGF-siRNA, a significant reduction of mRNA and protein levels of VEGF-A, VEGF-C and MMP2 was observed in the hilar cholangiocarcinoma cells. The invasion, migration and proliferation of tumor cells were also notably decreased. The rate of tumor cell apoptosis was increased in the VEGF-siRNA group (15.42%) compared with the non-siRNA control (2.22%) and the negative control (2.71%) groups. It was concluded that blocking the expression of VEGF via VEGF-siRNA effectively inhibited the invasion, migration and proliferation, and induced apoptosis in hilar cholangiocarcinoma cells. These observations suggested that targeting VEGF with RNAi may be an effective therapeutic strategy for treating hilar cholangiocarcinoma.
机译:本研究的目的是研究且可以抑制母族胆管癌细胞的增殖和转移是否可以通过小干扰RNA(siRNA)抑制血管内皮生长因子(VEGF)来诱导细胞凋亡。设计了靶向VEGF基因的siRNA序列,并用VEGF-siRNA质粒转染48小时转染人HALAR胆管癌QBC939,HCCC-9810和RBE细胞系。逆转录定量聚合酶链反应和蛋白质印迹测量VEGF-A,VEGF-C和基质金属蛋白酶2(MMP2)mRNA表达和蛋白质含量的水平。使用Transwell侵袭和迁移测定评估细胞侵袭电位,并且使用MTT测定来检测禽类胆管癌细胞的增殖。流式细胞术用于量化细胞凋亡和坏死。在VEGF-siRNA的转染后,在肝胆管癌细胞中观察到VEGF-A,VEGF-C和MMP2的mRNA和蛋白质水平的显着降低。肿瘤细胞的侵袭,迁移和增殖也显着降低。与非siRNA对照(2.22%)和阴性对照(2.71%)组相比,VEGF-siRNA组(15.42%)在VEGF-siRNA组(15.42%)中增加了肿瘤细胞凋亡的速率。得出结论,通过VEGF-siRNA阻断VEGF的表达有效抑制侵袭,迁移和增殖,以及肝胆管癌细胞的凋亡。这些观察结果表明,用RNAi靶向VEGF可能是治疗肺门胆管癌的有效治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号